Clinical Trial Update: Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

View source ↗

Summary

An update on a compassionate-use trial of ipilimumab for unresectable melanoma indicates the study is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Status: NO_LONGER_AVAILABLE